scholarly article | Q13442814 |
P2093 | author name string | Albert T | |
Eick D | |||
Kohlhuber F | |||
Hammersen B | |||
Urlbauer B | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Burkitt lymphoma | Q1016605 |
P304 | page(s) | 759-763 | |
P577 | publication date | 1994-03-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines | |
P478 | volume | 9 |
Q54585241 | 380 |
Q54797102 | BL-12 |
Q54797119 | BL-18 |
Q54797123 | BL-21 |
Q54797148 | BL-37 |
Q54797238 | BL-67 |
Q54797246 | BL-72 |
Q102113626 | BL-78 |
Q54797261 | BL-9 |
Q54832991 | EW-12 |
Q54832998 | EW-2 |
Q54833003 | EW-7 |
Q54897123 | IARC-171 |
Q54897138 | IARC-309 |
Q102114182 | IARC-591 |
Q54898919 | JI |
Q54898929 | Jiyoye |
Q54903329 | Ly67 |
Q54903979 | Maku |
Q54907095 | Mutu-1 |
Q54907132 | Mwika |
Q54937282 | P3HR-1 |
Q54993790 | WeWak1 |
Q36553239 | A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain |
Q55481055 | A polymorphic variant of human c-Myc: Asn11-->Ser. |
Q33797347 | Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. |
Q35082715 | Balance of Yin and Yang: ubiquitylation-mediated regulation of p53 and c-Myc |
Q37214654 | Burkitt's lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis |
Q39542337 | COP1 is a tumour suppressor that causes degradation of ETS transcription factors |
Q37114599 | Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity |
Q33964663 | Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma |
Q41063703 | Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells. |
Q41134120 | Erroneous class switching and false VDJ recombination: molecular dissection of t(8;14)/MYC-IGH translocations in Burkitt-type lymphoblastic leukemia/B-cell lymphoma |
Q36142180 | Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants |
Q34331166 | Glycosylation of the c-Myc transactivation domain |
Q36622715 | Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant |
Q33965061 | Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis |
Q39717211 | Multiple phenotypes associated with Myc-induced transformation of chick embryo fibroblasts can be dissociated by a basic region mutation |
Q38568550 | Myc: the beauty and the beast |
Q33625265 | O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress |
Q33742040 | Point Mutations in c-Myc Uncouple Neoplastic Transformation from Multiple Other Phenotypes in Rat Fibroblasts |
Q35018846 | Targeting c-MYC with T-cells |
Q33963949 | The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals |
Q33962550 | c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells |
Q39576244 | myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome |
Search more.